RCUS position history
The shares of Arcus Biosciences (RCUS) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 123,700 shares, $4.3M, 1.1% of portfolio
- 2021 Q4: 117,200 shares, $4.7M, 1.2% of portfolio, Reduce −5.3%
- 2022 Q1: 145,217 shares, $4.6M, 1.2% of portfolio, Add +23.9%
- 2022 Q2: 187,717 shares, $4.8M, 1.3% of portfolio, Add +29.3%
- 2022 Q3: 178,717 shares, $4.7M, 1.3% of portfolio, Reduce −4.8%
- 2022 Q4: 142,217 shares, $2.9M, 0.83% of portfolio, Reduce −20.4%
- 2023 Q1: 175,217 shares, $3.2M, 0.96% of portfolio, Add +23.2%
- 2023 Q2: 225,717 shares, $4.6M, 1.3% of portfolio, Add +28.8%
- 2023 Q3: 222,717 shares, $4M, 1.2% of portfolio, Reduce −1.3%
- 2023 Q4: 232,717 shares, $4.4M, 1.1% of portfolio, Add +4.5%
- 2024 Q1: 231,717 shares, $4.4M, 1.00% of portfolio, Reduce −0.4%
- 2024 Q2: 253,217 shares, $3.9M, 0.92% of portfolio, Add +9.3%
- 2024 Q3: 256,717 shares, $3.9M, 0.93% of portfolio, Add +1.4%
- 2024 Q4: 254,217 shares, $3.8M, 0.96% of portfolio, Reduce −1.0%
- 2025 Q1: 625,126 shares, $4.9M, 1.4% of portfolio, Add +145.9%
- 2025 Q2: 627,626 shares, $5.1M, 1.4% of portfolio, Add +0.4%
- 2025 Q3: 627,626 shares, $8.5M, 2.1% of portfolio
- 2025 Q4: 431,329 shares, $10M, 2.4% of portfolio, Reduce −31.3%
- 2026 Q1: 443,829 shares, $9.6M, 2.2% of portfolio, Add +2.9%
- 2026 Q2: 441,829 shares, $14M, 2.6% of portfolio, Reduce −0.5%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|